Jineane V Venci
Overview
Explore the profile of Jineane V Venci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Easton L, Vaid S, Nagel A, Venci J, Fortuna R
Am J Case Rep
. 2021 Dec;
22:e933999.
PMID: 34876549
BACKGROUND The increasing popularity and availability of herbal supplements among patients necessitates a better understanding of their mechanism of action and the effects they have on the body, both intended...
2.
Carroll J, Farah S, Fortuna R, Lanigan A, Sanders M, Venci J, et al.
Ann Intern Med
. 2019 May;
170(9_Suppl):S46-S53.
PMID: 31060055
Background: Medications contribute to patients' out-of-pocket costs, yet most clinicians do not routinely screen for patients' cost-of-medication (COM) concerns. Objective: To assess whether a single training session improves COM conversations....
3.
4.
Amer M, Cipriano G, Venci J, Gandhi M
J Hum Lact
. 2015 Apr;
31(3):348-53.
PMID: 25881578
The increasing popularity and use of dietary supplements has required health care professionals to become more knowledgeable of their properties, interactions, and adverse effects. The objectives of this review were...
5.
Venci J, Shamaskin J
Ann Allergy Asthma Immunol
. 2014 Oct;
113(6):666-7.
PMID: 25282368
No abstract available.
6.
Bonacci J, Venci J, Gandhi M
J Pharm Pract
. 2014 Aug;
28(5):473-8.
PMID: 25092604
In January 2014, the US Food and Drug Administration approved tasimelteon (Hetlioz™), a melatonin-receptor agonist for the treatment of non-24-hour sleep-wake disorder. This article provides an overview of the mechanism...
7.
Saraceni M, Venci J, Gandhi M
J Pharm Pract
. 2014 Jan;
27(4):389-95.
PMID: 24381243
In July 2013, the US Food and Drug Administration approved levomilnacipran extended release (ER; Fetzima), a serotonin-norepinephrine reuptake inhibitor, for the treatment of adults with major depressive disorder. Levomilnacipran is...
8.
Venci J, Gandhi M
Ann Pharmacother
. 2013 Nov;
47(12):1697-702.
PMID: 24259625
Objective: To describe the clinical evidence supporting the safety, efficacy, and clinical utility of oral dimethyl fumarate for the treatment of multiple sclerosis (MS). Data Sources: A comprehensive PubMed search...
9.
Venci J, Rowcliffe M, Wollenberg L, Rainka M, Gengo F
Forensic Sci Med Pathol
. 2012 Aug;
9(1):73-6.
PMID: 22915321
The antiepileptic, carbamazepine, is extensively metabolized via hepatic enzymes in the cytochrome P450 family and is therefore subject to a myriad of drug interactions. Concomitant administration with phenytoin enhances carbamazepine...